Hyderabad-based biopharmaceutical company Suven Life Sciences Ltd said it secured two product patents from Japanese Patent Office (JPO) for its new chemical entities (NCE's) which is for the treatment of disorders associated with neurodegenerative diseases. The patents are valid till 2022. With these a total of three Japanese product patents are granted to Suven, the company said in a statement to the exchanges.
According to the invention patent disclosure, the compounds are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia. These granted patents are exclusive intellectual property of Suven and are achieved through the internal drug discovery research efforts. Products out of these inventions may be out-licensed at the stage of clinical phase-I or phase-II, it added.
On Wednesday, Suven shares ended 4.9% higher at Rs29 on the Bombay Stock Exchange, while the benchmark Sensex closed at 0.3% up at 17,462 points.
Mumbai-based PBA Infrastructure Ltd said it won a contract, worth Rs14.33 crore from Maharashtra Industrial Development Corporation (MIDC).
PBA would construct WMM road with asphalt treatment including central road divider and allied work at IT Park-II (Phase-I) at Nagpur (Butibori) Industrial Area.
On Wednesday, PBA Infrastructure shares ended 0.3% up at Rs75 on the Bombay Stock Exchange, while the benchmark Sensex closed at 0.3% up at 17,462 points.
Hyderabad-based Vivimed Labs Ltd said it formed a manufacturing alliance with New Jersey-based chemical supplier International Specialty Products Inc (ISP) for production of ultraviolet (UV) absorbers. No financial details were provided.
The manufacturing alliance will allow the two companies to jointly market specific products used in sprays and lotions that include UVA and UVB protective properties.
From October onwards, ISP will add a number of UVA and UVB absorbers manufactured by Vivimed to its portfolio of sun protection ingredients.
On Wednesday, Vivimed shares gained 1.1% to Rs168 on the Bombay Stock Exchange, while the benchmark Sensex closed at 0.3% up at 17,462 points.